(Q39486529)

12 September 2017

title

Chiral ruthenium(II) anthraquinone complexes as dual inhibitors of topoisomerases I and II. (English)

1 reference

12 September 2017

1 reference

1 reference

Jun-Feng Kou

1

1 reference

12 September 2017

Chen Qian

2

1 reference

12 September 2017

Jin-Quan Wang

3

1 reference

12 September 2017

Xiang Chen

4

1 reference

12 September 2017

Li-Li Wang

5

1 reference

12 September 2017

Hui Chao

6

1 reference

12 September 2017

Liang-Nian Ji

7

1 reference

12 September 2017

publication date

21 August 2011

1 reference

Journal of Biological Inorganic Chemistry

12 September 2017

published in

1 reference

12 September 2017

volume

17

1 reference

12 September 2017

issue

1

1 reference

12 September 2017

page(s)

81-96

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

12 September 2017

1 reference

DNA topoisomerases: structure, function, and mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Cellular roles of dna topoisomerases: a molecular perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Camptothecin: current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Optimization of the indenone ring of indenoisoquinoline topoisomerase I inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Exploring DNA topoisomerase I inhibition by the benzo[c]phenanthridines fagaronine and ethoxidine using steered molecular dynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Etoposide, topoisomerase II and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Acridine-based agents with topoisomerase II activity inhibit pancreatic cancer cell proliferation and induce apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

DNA topoisomerase II in therapy-related acute promyelocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Antitumor activity of a novel quinoline derivative, TAS-103, with inhibitory effects on topoisomerases I and II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Inhibition of nucleotide excision repair and sensitisation of cells to DNA cross-linking anticancer drugs by F 11782, a novel fluorinated epipodophylloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Antitumor triptycene bisquinones: a novel synthetic class of dual inhibitors of DNA topoisomerase I and II activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Terpyridine-platinum(II) complexes are effective inhibitors of mammalian topoisomerases and human thioredoxin reductase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Design and synthesis of heterobimetallic topoisomerase I and II inhibitor complexes: in vitro DNA binding, interaction with 5'-GMP and 5'-TMP and cleavage studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Synthesis, DNA-binding and topoisomerase inhibitory activity of ruthenium(II) polypyridyl complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

DNA binding and topoisomerase II inhibitory activity of water-soluble ruthenium(II) and rhodium(III) complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Targeting topoisomerase II with the chiral DNA-intercalating ruthenium(II) polypyridyl complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Synthesis, GC selective DNA binding and topoisomerase II inhibition activities of ruthenium(II) polypyridyl complex containing 11-aminopteridino[6,7-f][1,10]phenanthrolin-13(12H)-one

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Effect of ancillary ligands on the topoisomerases II and transcription inhibition activity of polypyridyl ruthenium(II) complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Merbarone inhibits the catalytic activity of human topoisomerase IIalpha by blocking DNA cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Performance of the comet assay in a high-throughput version

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Synthesis, characterization, DNA-binding and photocleavage studies of [Ru(bpy)2(PPIP)]2+ and [Ru(phen)2(PPIP)]2+.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Complex formation between ethidium bromide and nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Theoretical calculations of the helix-coil transition of DNA in the presence of large, cooperatively binding ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Syntheses of ruthenium(II) quinonediimine complexes of cyclam and characterization of their DNA-binding activities and cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

DNA topoisomerases as targets for the anticancer drug TAS-103: DNA interactions and topoisomerase catalytic inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Kinetic cell-based morphological screening: prediction of mechanism of compound action and off-target effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Synthesis, antiproliferative, and antiplatelet activities of oxime- and methyloxime-containing flavone and isoflavone derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

A simple technique for quantitation of low levels of DNA damage in individual cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Immunocytochemical detection of 5-bromo-2-deoxyuridine incorporation in individual cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

21 January 2018

Caspases: enemies within

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

VP1686, a Vibrio type III secretion protein, induces toll-like receptor-independent apoptosis in macrophage through NF-kappaB inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Inhibitory properties of antitumor prostaglandins against topoisomerases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Benzothiopyranoindole-Based Antiproliferative Agents: Synthesis, Cytotoxicity, Nucleic Acids Interaction, and Topoisomerases Inhibition Properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00775-011-0831-6

Tris(phenanthroline)ruthenium(II) enantiomer interactions with DNA: mode and specificity of binding

21 January 2018

1 reference

12 December 2020

Ruthenium(II) polypyridyl complexes: potential precursors, metalloligands, and topo II inhibitors

1 reference

12 December 2020

The interaction of [Ru(NH3)5Cl]2+ and [Ru(NH3)6]3+ ions with DNA

1 reference

12 December 2020

Apoptosis and programmed cell death in health and disease.

1 reference

12 December 2020

Targeting apoptosis pathways in cancer therapy

1 reference

12 December 2020

Ruthenium(II) complexes of redox-related, modified dipyridophenazine ligands: synthesis, characterization, and DNA interaction

1 reference

12 December 2020

DNA topoisomerase II from Drosophila melanogaster. Relaxation of supercoiled DNA.

1 reference

12 December 2020

Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: structure-activity relationship

1 reference

12 December 2020

Inhibition of topoisomerases by antitumor prostaglandins

1 reference

12 December 2020

Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding site.

1 reference

12 December 2020

Studies on interaction of anthracycline antibiotics and deoxyribonucleic acid: equilibrium binding studies on interaction of daunomycin with deoxyribonucleic acid

1 reference

12 December 2020

Molecular Interactions of DNA-Topoisomerase I and II Inhibitor with DNA and Topoisomerases and in Ternary Complexes: Binding Modes and Biological Effects for Intoplicine Derivatives

1 reference

12 December 2020

A fluorescent complex between ethidium bromide and nucleic acids. Physical-chemical characterization

1 reference

12 December 2020

10.1007/S00775-011-0831-6

Identifiers

DOI

1 reference

12 September 2017

1 reference